Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ki-1 lymphomas in children.

B Schnitzer1, M S Roth, D M Hyder

  • 1Department of Pathology, University of Michigan Medical Center, Ann Arbor.

Cancer
|March 15, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safe administration of subsequent mRNA COVID-19 vaccine doses following a possible allergic reaction to the first dose.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

DOSE DEPENDENCE OF RADIATION INDUCED DAMAGE IN THE THERMOLUMINESCENT RESPONSE OF LIF:Mg,Ti (TLD-100).

Radiation protection dosimetry·2020
Same author

Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.

Journal of thrombosis and haemostasis : JTH·2016
Same author

The molecular biology of von Willebrand disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2013
Same author

Factors influencing tissue nitrate concentration in field-grown wild rocket (Diplotaxis tenuifolia) in southern England.

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment·2012
Same author

The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model.

Journal of thrombosis and haemostasis : JTH·2011
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
Same journal

Maintenance therapy in gynecologic malignancies: Current and future state.

Cancer·2026
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
See all related articles

This study reports on three pediatric Ki-1 lymphomas, a rare cancer. Two of the three children achieved remission with chemotherapy, highlighting treatment potential for this lymphoma subtype.

Area of Science:

  • Pediatric Oncology
  • Hematopathology
  • Immunology

Background:

  • Ki-1 lymphomas, a distinct subtype of non-Hodgkin lymphoma, are rare in children.
  • Understanding the immunophenotype and genetic characteristics is crucial for diagnosis and treatment.

Observation:

  • Three male pediatric patients presented with Ki-1 lymphomas involving lymph nodes.
  • Histological classification included immunoblastic and mixed small/large cell types.
  • Immunophenotyping revealed specific cell surface markers (e.g., Ki-1, LCA, EMA).

Findings:

  • DNA analysis showed germline patterns for immunoglobulin and T-cell receptor genes, suggesting a non-clonal origin or early developmental stage.
  • Multi-agent chemotherapy was administered to all patients.

Related Experiment Videos

  • Two patients achieved complete remission, while one had persistent disease.

    • Implications:

    • Ki-1 lymphomas in children, despite their rarity, may respond to chemotherapy.
    • Further research into the pathogenesis and optimal treatment strategies for pediatric Ki-1 lymphomas is warranted.
    • Germline DNA patterns may have diagnostic or prognostic significance in pediatric Ki-1 lymphomas.